COMPANY GROWTH
"I am proud to announce that AOP Orphan took over the health care companies AMOMED  and SciPharm!“

Andreas Steiner | CEO | CHAIRMAN OF THE BOARD

READ MORE
Mag. Andreas Steiner CEO | Chairman of the Board

"AOP Orphan is the European pioneer in Orphan Diseases unconditionally committed to bringing not only drugs but full treatment support to patients with rare diseases."

Dr. Gunther Krumpl Chief Corporate Development Officer | Board Member

"AOP Orphan having international expertise in pharmaceutical and clinical development as well as distribution and marketing of drugs in the rare disease area offers flexible solutions for in- and out-licensing partnerships."

Dr. Rudolf Widmann Chief Therapeutics Development Officer | Board Member | Founder

"As a company, we are small enough to be really close to our patients, yet we are large enough to be able to provide them high-quality, personalized customer care."